Precision Biosciences Inc
DTIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357874
In the last 90 days, Precision Biosciences Inc insiders filed 2 open-market purchases and 0 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Precision Biosciences Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- 0 vs. Q3 2022
- Shares held
- 50.5M
- −1.22M (−2.4%) vs. Q3 2022
- Total value
- $60.1M
- −$7.00M (−10.4%) vs. Q3 2022
- New holders
- 18
- 21 more added
- Sold out
- 18
- 35 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DTIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $138.9M |
| Q1 2026 | 78 | $88.1M |
| Q4 2025 | 69 | $62.8M |
| Q3 2025 | 56 | $25.7M |
| Q2 2025 | 52 | $18.6M |
| Q1 2025 | 48 | $18.1M |
| Q4 2024 | 55 | $14.7M |
| Q3 2024 | 51 | $29.8M |
| Q2 2024 | 47 | $30.8M |
| Q1 2024 | 43 | $42.8M |
| Q4 2023 | 66 | $12.8M |
| Q3 2023 | 77 | $11.8M |
| Q2 2023 | 77 | $23.0M |
| Q1 2023 | 86 | $36.5M |
| Q4 2022 | 102 | $60.1M |
| Q3 2022 | 103 | $67.2M |
| Q2 2022 | 121 | $93.5M |
| Q1 2022 | 153 | $96.6M |
| Q4 2021 | 134 | $233.4M |
| Q3 2021 | 132 | $336.5M |
| Q2 2021 | 131 | $357.6M |
| Q1 2021 | 128 | $313.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Precision Biosciences Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 5,035,971 | $5.99M | 0.18% | 00.0% | Unchanged |
| Capital World Investors | 6,715,043 | $7.99M | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −492,517−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −126,729−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −35,474−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,577−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −20,077−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −19,333−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −18,618−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −18,027−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −14,466−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −11,381−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −9,905−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −4,373−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −998−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −1,038−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |